Many breast cancer survivors and advocates were vocal and skeptical in response to the new US Preventive Services Task Force (USPSTF) recommendations on breast cancer screening.1 Members of the advocacy community have spent countless hours to raise awareness about breast cancer and to help provide access and services to those without sufficient insurance. Given this degree of dedication, it is understandable that response to the release of the USPSTF recommendations was so passionate. As a member of this community and also of the academic medical community, I understand the controversy about the current state of screening and prevention but also recognize that the issue is complex and nuanced and will require the attention and efforts of clinicians to provide the best individualized care for their patients.